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Abstract  
Biological monitoring of early genotoxic effects in urothelial cells using the urinary micronucleus 
(MNu) assay is promising for early detection of cancer, such as bladder carcinoma. But many 
problems are encountered, the major being the poorly differential staining of cells, particularly in 
women having an important amount of squamous cells. We have optimized the protocol and obtained 
a differential staining of the cell types present in urine on 10 subjects. Following Carnoy I fixation and 
Papanicolaou staining, urothelial cells were blue while most squamous cells were pink. This 
differential staining allowed for optimization of the MNu assay on a single urine void, for both 
females and males. Even if our MNu means were comparable to the literature, the great variation in 
reported MNu results could reside in the ability of scorers to distinguish correctly between urothelial 
and squamous cells. When monitoring exposed populations, this erroneous distinction could largely 
influence the results, even more in women’s urine samples. Given a situation where exposure would 
not increase micronuclei frequency in vaginal squamous cells, their erroneous analysis in the MNu 
assay could mask an early genotoxic effect. Therefore, as transitional cell carcinoma of the bladder 
originates from transformed urothelial cells, restricting micronuclei analysis to urothelial cells could 
yield a more precise estimate of cancer risk in exposed populations. Moreover, it is hoped that the 
improvements proposed in this paper will allow for an easier implementation of the MNu assay in 
various set-ups and enhance its specificity, since MNu are considered a suitable biomarker. 
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Introduction  
Bladder cancer has been associated with exposure to chemicals present in environmental and 
occupational settings, such as arsenic in drinking water (Basu et al., 2002), 4,4'-methylenebis-(2-
chloroaniline) used in manufacturing of wear-resistant polyurethane products (Murray and Edwards, 
1999) or occupational exposure as a painter (Straif et al., 2007). In particular, exposure to polycyclic 
aromatic hydrocarbons (PAHs) present in coal gasification and aluminium production industries, in 
mixtures of coal-tar pitch, coal tar and asphalt (Straif et al., 2005), as well as in tobacco smoke 
(Burgaz et al., 1995; DeMarini, 2004), reveal a statistically significant excess risk of bladder cancer. 
Urothelial carcinoma (or transitional cell carcinoma) is the most common form of bladder cancer, 
representing 90% of bladder tumors. Urothelial carcinoma can arise in every part of the urinary tract, 
from ureters to urethra, although bladder is the most common site. Being frequently present on 
multiple sites, this tumor is thought to arise following the action of carcinogens on the urinary tract 
and subsequent neoplastic transformation of the bladder epithelium cells (McKee, 2003).  
The normal bladder epithelium, called urothelium, is lined with superficial cells, known as 
umbrella cells. These are often large binucleated or larger multinucleated cells, covering several layers 
of deeper (cuboidal) urothelial cells, formerly known as transitional cells. Cuboidal urothelial cells are 
smaller than the umbrella cells, with a single nucleus, and show little variation in size. They are 
attached to each other and to the umbrella cells with numerous desmosomes. In voided urine, many 
epithelial cell types can be found: umbrella cells, cuboidal urothelial cells (occurring singly or in 
cluster), squamous cells, and renal tubular cells. In males, squamous cells are not frequent and are of 
urethral origin. More abundant in females, squamous cells originate either from the trigone of the 
bladder or from the vagina, through contamination of the urine with vaginal fluid (Koss and Melamed, 
2005b; McKee, 2003). In addition, squamous cell types of the urine vary, according to the hormonal 
status of the women. Superficial and intermediate squamous cells are found in urine samples taken 
 4
from women in childbearing age, while navicular (with glycogen deposits) and parabasal (which are 
the progenitor cells) squamous cells will exfoliate only during specific hormonal conditions such as 
pregnancy, breastfeeding period, menopause or progesterone hormone therapy (Koss and Melamed, 
2005c).  
Urinary cytology on voided specimen has been used for long term follow-up of industrial 
workers exposed to a bladder carcinogen (p-aminodiphenyl), but has failed in the detection of low-
grade tumors. Only high-grade urothelial tumors and flat carcinoma in situ of the bladder could be 
readily detected, suggesting that these cancers were not preceded by a precursor (dysplastic) stage 
detectable with urinary cytology on voided specimens (Koss and Melamed, 2005d). Nevertheless, it is 
expected that monitoring for early biological effects occurring prior to neoplastic transformation of 
urothelial cells could be done on the target tissue, by using the urinary micronucleus (MNu) assay. 
Following arsenic exposure through drinking of contaminated water, an increase MNu frequency was 
observed in populations living in many countries, including India, Chile, China and United States 
(Basu et al., 2002; Biggs et al., 1997; Tian et al., 2001; Warner et al., 1994). Also, a follow-up study 
revealed a decreased frequency of MNu in individuals who lowered their intake of water contaminated 
with arsenic (Moore et al., 1997a), suggesting the usefulness of this urinary assay in environmental 
health. Since then, many groups have used the MNu assay to perform biological monitoring of 
individuals living in Cs137 radionuclide-contaminated regions (Jen et al., 2002), as well as in workers 
exposed to various chemicals, such as 4,4’-methylenebis-(2-chloroaniline) (Murray and Edwards, 
1999), sodium nitrite and n-phenyl-1-naphtylamine (Fontana et al., 2001). Workers exposed to PAHs 
through bitumen fumes and emanations from coke ovens have also been monitored for increased 
micronuclei frequency in urothelial cells (Murray and Edwards, 2005; van Delft et al., 2001). Thus, 
MNu assay is considered to be a suitable biomarker of bladder cancer risk (Majer et al., 2001). 
Still, many problems are encountered, making interpretation of the MNu assay difficult: 
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insufficient number of analysable cells in the preparation (Rosin and Anwar, 1992; Tian et al., 2001; 
van Delft et al., 2001), or contamination of the urine sample with bacteria or fungi (Basu et al., 2004). 
This led to the collection of many urine specimens for a given subject (Basu et al., 2004; Fontana et 
al., 2001; Moore et al., 1997b), or to a low success rate (45 - 60 %) for this technique in some studies 
(Rosin and Anwar, 1992; van Delft et al., 2001). In addition, the presence in women’s urine sample of 
a large number of undesired squamous cells, that are difficult to differentiate with urothelial cells 
(Warner et al., 1994), limits biological monitoring, in comparison to male populations (Moore et al., 
1997b). To get rid of the squamous cells problem, enrichment in urothelial cells from female urine 
sediments using magnetic cell sorting has been described (Dorrenhaus et al., 2007), but this technique 
seems limited to biochemical applications. At the moment, as no other developments in the MNu assay 
have been described to allow suitable preparation of urothelial cells, excellent urine specimens and a 
very good cytological knowledge are necessary for analysis (Espinoza et al., 2008).  
In order to address these issues, our objectives were to optimize the sample collection for 
women and men, and obtain a differential staining between urothelial and squamous cells. To do so, 
we compared two commonly used fixatives, methanol (Dorrenhaus et al., 2007; Titenko-Holland et al., 
1994) and Carnoy I (Ghosh et al., 2006; Jen et al., 2002), as well as two staining methods, Giemsa 
(Ghosh et al., 2006; van Delft et al., 2001) and the Papanicolaou technique (Koss and Melamed, 
2005a). Giemsa is used to produce high-quality staining of the chromatin and nuclear membrane of all 
cell types (Barcia, 2007), while Papanicolaou is commonly used in urinary cytology for diagnostic of 
high-grade urothelial tumors (Koss and Melamed, 2005d; McKee, 2003). 
 
Materials and Methods 
Subjects 
5 females and 5 males, aged between 20 and 60 years, were selected. All were healthy non-
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smokers, with no history of abnormal urinary cytology, bladder cancer or any other cancer. Three of 
the women were using contraceptive pills (21, 26 and 34 years), while the other two were in early 
post-menopause (51 and 58 years). This research was approved by the research ethical board of our 
institutions and all subjects provided informed consent to participate in this study. 
 
Collection of urine specimens 
A midstream clean catch collection of urine from the second or third voids of the day was 
requested from the subjects (Koss and Melamed, 2005b). Before urine collection, participants were 
asked to wash extensively their urethral area, including the labiae in women, with flushable 
premoistened wipes, and to void the first portion of the urine stream into the toilet. The midstream 
urine was then collected in sterile containers. These procedures were adopted to limit the 
contamination of urine with squamous cells coming from vaginal fluids of female, as well as to limit 
the microbial contamination of urine from both sexes. Midstream urine was processed within 2 h. 
Volume of voided specimens varied from 50 ml and 250 ml; several trials were done to determine the 
best sample volume for female and male. Some male subjects were required to raise their hydration 
level by drinking one glass of water (approximately 250 ml) every 30 minutes, for 3 hours before the 
void, in order to increase the amount of desquamated urothelial cells in urine (Koss and Melamed, 
2005b). 
 
Isolation of exfoliated cells in urine 
As urine of males contains considerably less cells than urine of females, we modified the 
isolation procedure of Lehucher-Michel et al. (1996) to minimize cell loss. Urine samples were first 
centrifuged at 400 × g for 10 min in 250 ml centrifuge plastic bottle (Fisher Scientific Company, 
Ottawa, On, Canada). The supernatant was carefully discarded, leaving 10 to 15 ml urine in the bottle. 
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The pellet was resuspended and transferred to a 15 ml conical centrifuge tube (Sarstedt inc., Montreal, 
QC, Canada). A second centrifugation was performed at 400 × g for 10 min. The supernatant was 
again discarded, leaving 0.5 ml to ensure no cell loss, especially in urine samples from males. The cell 
pellet was washed with 10 ml sterile NaCl 0.9 % and centrifuged at 400 × g for 10 min. At this step, 
half the samples of both females and males, presented a cloudy material stacked on top of the cell 
pellet. The material, present in the supernatant, was separated and processed further in the same way 
as the cell pellet. Microscopic observation of the cloudy material revealed that there were no well 
preserved urothelial cells in this fraction. It mostly contained well preserved squamous cells, some 
neutrophils and cellular debris; this material was therefore discarded. After a second wash, the final 
pellet was resuspended in 1.0 ml sterile NaCl 0.9 %. For samples from males, the pellet was 
transferred in a 1.5 ml microtube, and further centrifuged at 10 000 × g for 1 minute. Most of the 
supernatant was removed and the pellet was resuspended in 0.2 ml sterile NaCl 0.9 %. The final 
volumes obtained after cell isolation for female and male samples (1 and 0.2 ml respectively) reflect 
the differences in the size of the cell pellets. 
 
Fixation and staining of exfoliated cells in urine 
Different combinations of fixatives and staining were used during the optimization process. 
Fixation was performed using either 100 % methanol (Fisher Scientific Company) or Carnoy I fixative 
(methanol:glacial acetic acid, 3:1; Fisher Scientific Company). Pellets were resuspended in the fixative 
and fixed twice (10 ml for female; 1.5 ml for male) for 10 minutes. After fixation, pellets were 
resuspended in 0.5 ml (female) or 25 µl (male) fixative.  One cell spread on precleaned microscope 
slide (Fisher Scientific Company) was prepared for each female and male sample. Slides were air 
dried overnight and staining was performed, using Giemsa or Papanicolaou.  
Giemsa staining was realized with freshly filtered 4% Giemsa diluted in Gurr’s pH 6.8 buffer 
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(both from Invitrogen, Burlington, ON, Canada). The Papanicolaou technique was done according to 
Koss and Melamed (2005a) using a DRS-601 automatic slide stainer (Sakura Finetek USA, inc., 
Torrance, CA, USA). Briefly, slides were stained in Harris hematoxylin (ACP Chemicals inc., 
Montreal, QC, Canada). A differential extraction of the hematoxylin with 0.25 % HCl (Fisher 
Scientific Company) was done before dehydration and followed by a subsequent cytoplasmic staining 
with orange G (OG-6; ACP Chemicals inc.) and eosin (EA-65; VWR International, Mississauga, ON, 
Canada). Slides were then conditioned in xylene (Fisher Scientific Company) and mounted using a 
Tissue-Tek coverslipper (Sakura Finetek USA, inc.).  
 
Micronuclei scoring procedure and criteria 
Following optimization of isolation and differential coloration of the exfoliated cells, the MNu 
assay was performed on samples obtained from the 10 participants. Slides were screened at 400× 
magnification on a Leica Laborlux microscope (Leica Microsystems Canada inc., Richmond Hill, ON, 
Canada) and only cells with an intact nucleus that were not clumping or overlapping, were chosen. 
Micronuclei were scored following a modification of the Fenech (2007) and Reali (1987) criteria, as 
urothelial cells frequently contain cytoplasmic inclusions (Koss and Melamed, 2005b) that can be 
mistaken for micronuclei. These criteria were: (a) being less than 1/3 and more than 1/16 diameter 
than the main nucleus, (b) being on the same focus plane, while (c) not superimposing to the main 
nucleus, (d) having the same color, texture and refraction as the main nucleus, (e) having a smooth 
round or oval shape, and (f) having limits clearly distinguishable from the main nuclear membrane if 
touching the main nucleus. Inclusions are usually smaller (less than 1/16 diameter) and mostly on a 
different focus plane than the main nucleus. 1000 urothelial cells were analyzed at 1000× 
magnification, for the presence of micronuclei. All micronuclei were confirmed by a second observer. 
Microphotographs were obtained with a SPOT RT color camera, using the SPOT imaging software, 
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version 4.1 (Diagnostic Instruments inc., Sterling Heights, MI, USA).   
 
Results 
Collection and isolation of exfoliated cells 
In general, an efficient isolation of urothelial cells present in urine samples from both the 
females and the males could be readily performed. For males, a minimum urine specimen of 250 ml 
was required. One male needed to provide a new urine specimen so that 1000 cells could be analysed 
in a single sample. Finally, another male subject was excluded and replaced, as his urine samples 
provided only a few urothelial cells, even after hydration was augmented.  
As for the women, a urine specimen of 100 ml provided enough urothelial cells to perform the 
MNu assay. Two females were asked to wash more thoroughly their labiae and urethral area before 
providing a second urine specimen, in order to reduce contamination with bacteria or fungi, and the 
number of squamous cells. Indeed, the squamous cells represented more than 95% of the cells present 
in their samples. The midstream clean catch collection of urine, as well as the careful cleaning of 
urethral region, clearly reduced the amount of bacteria and squamous cells in urine samples of 
females.  
 
Fixation and staining of exfoliated cells 
When Giemsa or Papanicolaou staining were done after methanol fixation (Fig. 1A and B, 
respectively), this resulted in a loss of morphological features: urothelial cells (U) were roundish, with 
their nucleus nearly black and not clearly delineated. Squamous cells (S) and urothelial cells were 
blue, their nucleus barely visible and the cytoplasm of urothelial cells being darker than that of 
squamous cells. With Carnoy I fixation and Giemsa staining (Fig. 1C), squamous and urothelial cells 
presented the same violet color. Urothelial cells were again roundish, their cytoplasm was not sharply 
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demarcated, and the nucleus, again, was not clearly delineated.  
Carnoy I fixation followed by the Papanicolaou technique provided the best results (Fig. 1D to 
F). A differential staining was achieved, as most of the squamous cells appeared red to pink, while the 
urothelial cells were light blue. Furthermore, in women’s urine samples, we could determine that blue 
cuboidal urothelial cells represented 5 to 10 % of the cells, compared to 90 to 95 % of squamous cells, 
of which 83 % were pink superficial squamous cells, while 17 % were blue intermediate ones. Table 1 
summarizes the main morphological features of urothelial and squamous cells. Morphology of 
urothelial cells was well preserved with a sharply demarcated cytoplasm, and a dark blue nucleus 
clearly delineated presenting chromatin textures. The size of the nucleus was big when compared to 
the size of the cell (nuclear-cytoplasmic ratio is around 1:2 to 1:5). In urothelial cell clusters, 
desmosomal attachment points (small arrows in Fig. 1D) led to a cytoplasm stretching. Occasionally, 
blue intermediate squamous cells (I) originating either from the vagina or the trigone (Fig. 1F) could 
be found, but were much larger in size than cuboidal urothelial cells. More rarely, some of these 
intermediate cells called navicular cells, also showed yellowish glycogen deposits. Another distinctive 
feature of the vaginal squamous cells is the presence of bacilli-type bacteria on their cytoplasm.  
 
Micronuclei analysis in urothelial cells 
Usually, enough urothelial cells were present on one slide per subject to perform the MN 
analysis. MN analysis was performed only on “blue” cuboidal urothelial cells. Rarely present, 
umbrella cells were also analysed for the presence of a micronucleus, as they are part of the 
urothelium and derive from urothelial cells. Some urothelial cells contained one or more cytoplasmic 
inclusions that could be easily distinguished from a micronucleus since they were not on the same 
focus plane and were too small (less than 1/16 diameter of the main nucleus). Representative 
micronucleus (MNu) and cytoplasmic inclusions (stars) present in a urothelial cell analysed at 1000× 
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magnification is shown in Figure 1E. The micronuclei frequency per thousand analysed cells for each 
subject is presented in Table 2. Briefly, we report a mean frequency of 2.6 ± 1.6 MNu per thousand 
urothelial cells for females, and 3.0 ± 1.4 for male subjects. On the other hand, some blue intermediate 
squamous cells also presented a micronucleus (Figure 1F), but they were not included in the 
calculation of the micronuclei frequency in urothelial cells.  
 
 
Discussion  
The MNu assay was developed in 1982, based on the blood micronucleus (MN) assay (Stich et 
al., 1982). Since then, many fixation methods have been described, using either methanol alone or 
Carnoy I fixative before or after cells were spread onto slides. In urine cytology, a 20:1 mix of 
methanol and acetic acid has also been described as a liquid-based fixative (Koss and Melamed, 
2005a). As for staining methods, Feulgen reaction counterstained with Fast green (Moore et al., 1993; 
Rosin and Anwar, 1992), Diff-Quik (Murray and Edwards, 1999), and Giemsa stain (Ghosh et al., 
2006; Gonzalez Cid et al., 1991) are frequently used. Although these staining methods allow for clear 
demarcation between nucleus and cytoplasm (Majer et al., 2001), distinction between urothelial cells 
and other cell types present in urine, such as squamous cells, is mainly based on cytological features 
(Espinoza et al., 2008). Also, some studies report use of fluorescent in situ hybridization with a pan-
centromeric probe, with propidium iodide as a counterstain, to investigate the content of micronuclei 
present in urine preparations (Moore et al., 1997b; Warner et al., 1994). However, as urine samples 
taken from females contain numerous squamous cells from vaginal origin, many population studies 
have been restricted to males (Burgaz et al., 1995; Moore et al., 1997a; Moore et al., 1997b; 
Ranmuthugala et al., 2003), therefore limiting their applicability to only a subset of the exposed 
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population. 
During our optimization process, we combined several approaches taken from medical 
microbiology, urinary cytology, and the current MNu assay. We improved the technique via a reduced 
amount of vaginal squamous cells present in urine samples, and a differential staining of urothelial and 
squamous cells. This was achieved by an extensive washing of the urethral region, including the labiae 
for women, coupled with a midstream clean catch collection of voided urine specimen, as required for 
urinary microbiology cultures (Ronald and Alfa, 1996). In addition, the cells were fixed using Carnoy 
I, which is frequently used in MNu assay, and stained with the multichromatic Papanicolaou 
technique, as described in urinary cytology (Koss and Melamed, 2005a). This staining technique is 
used for diagnosis in clinical cytology, as it produces a differential staining allowing for the distinction 
between cell types present in a variety of biological samples. It had never been used before to perform 
the MNu assay, probably because development of this assay was based on the blood micronucleus 
assay, which did not required a differential staining. In clinical settings such as ours, this staining is 
regularly performed with an automatic slide stainer, but it can be easily realized manually within an 
hour (Koss and Melamed, 2005a). Even though Papanicolaou technique requires multiple steps when 
compared to Giemsa staining, its benefits are important as it allowed us to discriminate between 
urothelial and squamous cells, thus restricting analysis to urothelial cells, even if urine samples of 
women contained a high proportion of squamous cells, mainly from vaginal origin. Furthermore, the 
achieved differential staining limits the need for strong urine cytology knowledge, as urothelial cells 
are small cuboidal cells stained in blue, and most of the squamous cells are large, polygonal and pink. 
In women’s samples, some squamous cells staining in blue were noticed (Figure 1F). These were 
intermediate squamous cells of vaginal type who were also polygonal, the same size as superficial 
squamous cells (stained in pink), with their nucleus being slightly larger (Table 1). These 
characteristics made them easily distinguishable from the smaller cuboidal urothelial cells, even if they 
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presented the same blue coloration.  
Revision of women’s cytology suggested that an additional criterion should be added when 
selecting women for MNu studies, according to their hormonal status. During days 7 to 13 of the 
menstrual cycle, the proportion of mature superficial squamous cells present in the vaginal fluid 
(stained in pink) increases, in comparison to the blue intermediate ones, allowing for an easier 
discrimination between squamous and urothelial cells. In contrast, following ovulation, intermediate 
squamous cells (stained in blue) are more numerous in the vaginal fluid (Koss and Melamed, 2005c). 
On the other hand, particular hormonal conditions present in women, such as breastfeeding period, late 
post-menopause or some hormone therapies, all characterized by a lack of estrogenic activity, have an 
influence on the cell composition of the vaginal fluid. During these periods parabasal cells, stained in 
blue by the Papanicolaou technique, naturally exfoliate (Koss and Melamed, 2005c). Thus, when 
conducting a population-based study, a special attention should be given to urinary samples from 
women in the above-mentioned hormonal conditions. These samples should not be included in the 
MNu study. 
Overall, a success rate of 72% was reached for the isolation and micronuclei analysis of 
urothelial cells after reception of the first urine specimen of our subjects. Inclusion of the second urine 
specimen for three subjects raises our success rate to 91%, comparable with the reported success rates 
achieved on larger population samples (Basu et al., 2004; Fontana et al., 2001). Our analysis also 
confirmed that women exfoliate more urothelial cells than men. Using this improved technique, we 
obtained a mean frequency of 2.6 ± 1.6 and 3.0 ± 1.4 MNu/1000 urothelial cells for female and male 
subjects, respectively. Our values are within the mean frequencies reported for control cohorts in the 
literature (as reviewed in Table 3). However, a great variation in the MNu frequencies is reported 
among these control cohorts, and could be explained by many factors such as sex, age, lifestyle habits, 
geographic region and ethnicity, sample size, and scoring criteria (Espinoza et al., 2008; Majer et al., 
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2001). Nevertheless, we believe that one of the main factors could reside in the ability of the scorers to 
distinguish correctly between urothelial and squamous cells, during the MNu analysis. As all those 
control cohorts have no reported diseases, impact of erroneous analysis of a certain number of 
squamous cells is probably minor. But when monitoring exposed populations, this erroneous 
distinction could largely influence the results, even more if squamous cells represent a large proportion 
of cells present in women’s urine samples, as noticed in our study and by many authors (Dorrenhaus et 
al., 2007; Hofseth et al., 1996; Moore et al., 1997a; Stich et al., 1982). For example, given a situation 
where exposure to a compound did not increase the MN frequency in squamous cells from vaginal 
origin, but increased it in urothelial cells, erroneous analysis of those squamous cells as part of the 
MNu assay would lower the resulting MNu frequency and mask a bladder genotoxic effect. The 
reverse situation could also be encountered and could be more common than previously thought, as 
even tobacco consumption alone has been associated with an increased MN frequency in exfoliated 
cells from the cervix (Majer et al., 2001). Since an increased MN frequency will be found in the target 
cells only when the metabolites reach the epithelia, or when the target cells have sufficient metabolic 
competence to activate the carcinogen (Majer et al., 2001), a bladder genotoxic substance will be 
detected if an accurate MNu frequency can be obtained upon analysis of the target cells, namely the 
urothelial cells. 
It is hoped that the improvements proposed in this paper will allow for an easier 
implementation of the MNu assay in various set-ups and enhance its specificity, since this assay is 
presently considered a suitable biomarker of bladder cancer risk. As transitional cell carcinoma of the 
bladder originates from transformed urothelial cells, restricting the micronuclei analysis to urothelial 
cells could result in a more precise estimate of cancer risk in exposed populations and lead to the 
implementation of better preventive measures in the living environment and at the workplace.  
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Figure 1  
Representative examples of results obtained with various fixation and staining methods of cells present 
in voided urine samples, and subsequent identification of micronuclei in squamous and urothelial cells. 
Urothelial cells (U), vaginal type superficial squamous cells (S), and intermediate squamous cells (I) 
are marked. (A) Methanol fixation and Giemsa staining of cells. (B) Methanol fixation and 
Papanicolaou staining. (C) Carnoy I fixation and Giemsa staining. In panels A, B and C, urothelial 
cells and squamous cells have alike blue or violet coloration. Also, urothelial cells have lost some of 
their morphological features and nuclei are not clearly delineated. (D), (E) and (F) Carnoy I fixation 
and Papanicolaou staining of cells. Differential staining of all cell types is achieved, as urothelial cells 
are blue while superficial squamous cells are red to pink, and intermediate squamous cells are blue. 
(D) Desmosomal attachment points (small arrows) are clearly visible between urothelial cells. (E) 
Presence of a micronucleus (MNu - long arrow), in an urothelial cell. Presence of cytoplasmic 
inclusions (stars) are also seen in some urothelial cells. (F) Presence of a micronucleus (MN – long 
arrow) in a blue intermediate squamous cell with glycogen deposits, identifying it as a navicular cell 
(N). Panels A, B, C and D at original magnification: 400×. Panels E and F at original magnification: 
1000×. 
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Figure 1
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Table 1 
Main morphological features of urothelial and squamous cells. 
Morphological 
features 
Urothelial cells Superficial 
squamous cells 
Intermediate 
squamous cells 
PAP coloration Blue Red to pink Blue 
Shape Cuboidal Polygonal Polygonal 
Relative size Small cells Large cells Large cells 
Nuclear-cytoplasmic 
ratio 
1:2 to 1:5 1:20 and more 1:15 to 1:20  
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Table 2 
Micronuclei analysis of urothelial cells in 10 subjects. Urine samples were fixed using Carnoy I and 
differentially stained using the Papanicolaou technique.  
 
 Male subjects Female subjects 
Subject code M1 M2 M3 M4 M5 a F1 F2 a F3 F4 F5 a 
MNu/ 1000 cells 3 2 4 5 1 5 3 3 0 2 
One thousand «blue» urothelial cells were analyzed per sample. 
a Analysis done on the second urinary sample.  
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Table 3  
Reported urinary micronuclei frequencies (per 1000 analyzed cells) in control (unexposed) subjects. 
Sex Urinary micronuclei frequency ± 
Standard deviation 
Number of 
subjects 
References 
nr 0.62 ± 0.52 ‰ a nr Moore et al., 1993 
M + F 0.53 ± 0.14 ‰ a 13 Tian et al., 2001 
M + F 0.56 ± 0.45 ‰ a 21 Basu et al., 2002 
M + F 2.73 ± 0.59 ‰ a 10 Jen et al., 2002 
Males 0- 20 ‰ b 30 Kassie et al., 2001 
Males 7.3 ± 1.8 ‰ 15 Gonzalez Cid et al., 1991 
Males 1.2 ± 0.4 ‰ 32 Rosin and Anwar, 1992 
Males 2.14 ± 0.46 ‰ 8 Warner et al., 1994 
Males 6.6 ± 0.5 ‰ 20 Burgaz et al., 1995 
Males 0.98 ± 0.3 ‰ 26 Hofseth et al., 1996 
Males 1.6 ‰ 19 Moore et al., 1997b 
Males 1.7 ‰ 85 Ranmuthugala et al., 2003 
Males 1.36 ± 0.041 ‰ 88 Basu et al., 2004 
Males 6.88 ± 0.18 ‰ 18 Murray and Edwards, 2005 
Males 3.0 ± 1.4 ‰ 5 Present study 
Mean Mnu frequency in males 3.28 ‰   
Females 0.83 ± 0.74 ‰ 5 Titenko-Holland et al., 1994  
Females 1.28 ± 0.31 ‰ 10 Warner et al., 1994 
Females 4.7 ± 3.1 ‰ 4 Lehucher-Michel et al., 1996 
Females 1.4 ± 0.3 ‰ 41 Fontana et al., 2001 
Females 1.48 ± 0.051 ‰ 66 Basu et al., 2004 
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Females 9.72 ± 0.82 ‰ 72 Espinoza et al., 2008 
Females 2.6 ± 1.6 ‰ 5 Present study 
Mean MNu frequency in females 3.14 ‰ 
nr: not reported 
M + F: Males and Females – grouped results 
a Values excluded for the calculation of the mean MNu frequencies, because both sexes were 
paired or not reported.  
b Value excluded for the calculation of the mean MNu frequency in males, because a frequency 
interval was given. 
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